| 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained M Zanoni, F Piccinini, C Arienti, A Zamagni, S Santi, R Polico, ... Scientific reports 6 (1), 19103, 2016 | 1062 | 2016 |
| Modeling neoplastic disease with spheroids and organoids M Zanoni, M Cortesi, A Zamagni, C Arienti, S Pignatta, A Tesei Journal of hematology & oncology 13, 1-15, 2020 | 185 | 2020 |
| Cell counting and viability assessment of 2D and 3D cell cultures: expected reliability of the trypan blue assay F Piccinini, A Tesei, C Arienti, A Bevilacqua Biological procedures online 19, 1-12, 2017 | 125 | 2017 |
| Epidermal growth factor receptor family and its role in gastric cancer C Arienti, S Pignatta, A Tesei Frontiers in oncology 9, 1308, 2019 | 116 | 2019 |
| Role of RAF/MEK/ERK pathway, p‐STAT‐3 and Mcl‐1 in sorafenib activity in human pancreatic cancer cell lines P Ulivi, C Arienti, D Amadori, F Fabbri, S Carloni, A Tesei, I Vannini, ... Journal of cellular physiology 220 (1), 214-221, 2009 | 94 | 2009 |
| Anticancer drug discovery using multicellular tumor spheroid models M Zanoni, S Pignatta, C Arienti, M Bonafè, A Tesei Expert opinion on drug discovery 14 (3), 289-301, 2019 | 90 | 2019 |
| Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells F Fabbri, D Amadori, S Carloni, G Brigliadori, A Tesei, P Ulivi, M Rosetti, ... Journal of cellular physiology 217 (2), 494-501, 2008 | 79 | 2008 |
| Sigma receptors as endoplasmic reticulum stress “gatekeepers” and their modulators as emerging new weapons in the fight against cancer A Tesei, M Cortesi, A Zamagni, C Arienti, S Pignatta, M Zanoni, M Paolillo, ... Frontiers in pharmacology 9, 711, 2018 | 69 | 2018 |
| Cancer multicellular spheroids: volume assessment from a single 2D projection F Piccinini, A Tesei, C Arienti, A Bevilacqua Computer methods and programs in biomedicine 118 (2), 95-106, 2015 | 67 | 2015 |
| Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer C Arienti, M Zanoni, S Pignatta, A Del Rio, S Carloni, M Tebaldi, G Tedaldi, ... Oncotarget 7 (14), 18424, 2016 | 55 | 2016 |
| Isolation of stem/progenitor cells from normal lung tissue of adult humans A Tesei, W Zoli, C Arienti, G Storci, AM Granato, G Pasquinelli, S Valente, ... Cell Proliferation 42 (3), 298-308, 2009 | 55 | 2009 |
| Activity of lipoplatin in tumor and in normal cells in vitro C Arienti, A Tesei, A Ravaioli, M Ratta, S Carloni, S Mangianti, P Ulivi, ... Anti-cancer drugs 19 (10), 983-990, 2008 | 48 | 2008 |
| Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians G Storci, S De Carolis, A Papi, MG Bacalini, N Gensous, E Marasco, ... Cell Death & Differentiation 26 (9), 1845-1858, 2019 | 46 | 2019 |
| In vitro irradiation system for radiobiological experiments A Tesei, A Sarnelli, C Arienti, E Menghi, L Medri, E Gabucci, S Pignatta, ... Radiation Oncology 8, 1-12, 2013 | 40 | 2013 |
| Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance M Zanoni, S Bravaccini, F Fabbri, C Arienti Frontiers in medicine 9, 795762, 2022 | 39 | 2022 |
| Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity A Tesei, G Brigliadori, S Carloni, F Fabbri, P Ulivi, C Arienti, A Sparatore, ... Journal of Cellular Physiology 227 (10), 3389-3396, 2012 | 35 | 2012 |
| Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma Z Michele, S Alba Clara, Z Alice, C Michela, P Sara, A Chiara, Michela, ... Cell Death Dis, 2022 | 30 | 2022 |
| TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer A Tesei, C Arienti, G Bossi, S Santi, I De Santis, A Bevilacqua, M Zanoni, ... Journal of Experimental & Clinical Cancer Research 40, 1-15, 2021 | 27 | 2021 |
| Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer S Pignatta, I Orienti, M Falconi, G Teti, C Arienti, L Medri, M Zanoni, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (2), 263-273, 2015 | 27 | 2015 |
| Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer C Arienti, A Tesei, GM Verdecchia, M Framarini, S Virzì, A Grassi, E Scarpi, ... Clinical Colorectal Cancer 12 (2), 122-127, 2013 | 27 | 2013 |
Anna TeseiIRST IRCCS在 irst.emr.it 的电子邮件经过验证
